Hepatocellular carcinoma (HCC) is a highly invasive malignancy prone to recurrence, and
patients with HCC have a low 5-year survival rate. Long non-coding RNAs (lncRNAs) play a …

5-Methyladenosine (m5C) is a type of epigenetic modification involved in the progression of
various cancers. To investigate the role of m5C-related long non-coding RNAs (lncRNAs) in …

Abstract LncRNA N6-methylandenosine (m6A) modification has been shown to be
associated with the constitution of the tumor microenvironment (TME) and tumorigenesis. It's …

Despite great advances in the treatment of liver hepatocellular carcinoma (LIHC), such as
immunotherapy, the prognosis remains extremely poor, and there is an urgent need to …

Background: RNA methylation modifications are important post-translational modifications
that are regulated in an epigenetic manner. Recently, N 6-methyladenosine (m 6 A) RNA …

Simple Summary The relationship between m1A-related lncRNAs and HCC is still unclear.
In this study, five m1A-related lncRNAs (AL031985. 3, NRAV, WAC-AS1, AC026412. 3, and …

Background N6-methyladenosine (m6A)-mediated ribonucleic acid (RNA) methylation is
considered to be the most significant and abundant epigenetic modification in eukaryotic …

Background: Hepatocellular carcinoma (HCC) remains the most prevalent gastrointestinal
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …

Abstract Background N6-methyladenosine (m6A) is a common modification and plays an
important role in various biological processes, but m6A-related lncRNA functions in …

The relationship between m6A-related lncRNAs and prognosis in hepatocellular carcinoma
(HCC) is not yet clear. We used Lasso regression to establish a prognostic signature based …